Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa

BMJ Global Health

Volumn 2, Issue 1, 2017, Pages

  Winskill, Peter ^a   Walker, Patrick G T ^a   Griffin, Jamie T ^a,b   Ghani, Azra C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85032183196     PISSN: None     EISSN: 20597908     Source Type: Journal    
DOI: 10.1136/bmjgh-2016-000090     Document Type: Article

References (34)

1. United Nations. Millennium Development Goals. 2015. http://www.un. org/millenniumgoals (accessed 20 Nov 2015).
2. World Health Organization. World Malaria Report. Geneva, Switzerland: World Health Organization, 2015.
3. Bhatt S, Weiss DJ, Cameron E, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 2015;526:207-11.
4. RTSS Clinical Trials Partnership. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 2015;386:31-45.
5. Penny MA, Verity R, Bever CA, et al. Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models. Lancet 2016;387:367-75.
6. Morel CM, Lauer JA, Evans DB. Cost effectiveness analysis of strategies to combat malaria in developing countries. BMJ 2005;331:1299.
7. Conteh L, Sicuri E, Manzi F, et al. The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. PLoS ONE 2010;5:e10313.
8. Elbasha EH, Messonnier ML. Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale. Health Econ 2004;13:21-35.
9. Bishai D, McQuestion M, Chaudhry R, et al. The costs of scaling up vaccination in the world's poorest countries. Health Aff 2006;25:348-56.
10. Griffin JT, Bhatt S, Sinka ME, et al. Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study. Lancet Infect Dis 2016;16:465-72.
11. Griffin JT, Ferguson NM, Ghani AC. Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa. Nat Commun 2014;5:3136.
12. Griffin JT, Hollingsworth TD, Reyburn H, et al. Gradual acquisition of immunity to severe malaria with increasing exposure. Proc Biol Sci 2015;282:20142657.
13. White MT, Griffin JT, Churcher TS, et al. Modelling the impact of vector control interventions on Anopheles gambiae population dynamics. Parasit Vectors 2011;4:153.
14. White MT, Verity R, Griffin JT, et al. Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial. Lancet Infect Dis 2015;15:1450-8.
15. National Weather Service. Climate Prediction Center. http://www.cpc.ncep.noaa.gov/products/international/ (accessed 24 Mar 2016).
16. Griffin JT, Hollingsworth TD, Okell LC, et al. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med 2010;7:e1000324.
17. USAID. The DHS Program. http://www.dhsprogram.com/ (accessed 17 Feb 2016).
18. Roll Back Malaria. Malaria Indicator Surveys. http://www.malariasurveys.org/ (accessed 17 Feb 2016).
19. World Health Organization. Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in children: a field guide. Geneva, Switzerland: World Health Organization, 2013.
20. White MT, Conteh L, Cibulskis R, et al. Costs and cost-effectiveness of malaria control interventions - a systematic review. Malar J 2011;10:337.
21. Wafula F, Agweyu A, Macintyre K. Regional and temporal trends in malaria commodity costs: an analysis of Global Fund data for 79 countries. Malar J 2013;12:466.
22. PMI. President's Malaria Initiative Africa Indoor Residual Spraying Project. 2012. http://www.africairs.net/ (accessed 5 Jun 2015).
23. CHAI. Coverage and cost-effectiveness of public and private sector delivery methods of seasonal malaria chemoprevention in Northern Nigeria. 2013. http://www.clintonhealthaccess.org/smc-nutritionnigeria/
24. MSF. Project summary note. Seasonal Malaria Chemoprevention (SMC), 2012.
25. Galactionova K, Bertram M, Lauer J, et al. Costing RTS, S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: a generalizable approach drawing on publicly available data. Vaccine 2015;33:6710-18.
26. Okell LC, Cairns M, Griffin JT, et al. Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis. Nat Commun 2014;5:5606.
27. Bhatt S, Weiss DJ, Mappin B, et al. Coverage and system efficiencies of insecticide-treated nets in Africa from 2000 to 2017. Elife 2015;4:e09672.
28. Howard SC, Omumbo J, Nevill C, et al. Evidence for a mass community effect of insecticide-treated bednets on the incidence of malaria on the Kenyan coast. Trans R Soc Trop Med Hyg 2000;94:357-60.
29. Pinder M, Jawara M, Jarju LBS, et al. Efficacy of indoor residual spraying with dichlorodiphenyltrichloroethane against malaria in Gambian communities with high usage of long-lasting insecticidal mosquito nets: a cluster-randomised controlled trial. Lancet 2015;385:1436-46.
30. West PA, Protopopoff N, Wright A, et al. Indoor residual spraying in combination with insecticide-treated nets compared to insecticide-treated nets alone for protection against malaria: a cluster randomised trial in Tanzania. PLoS Med 2014;11: e1001630.
31. Cairns M, Roca-Feltrer A, Garske T, et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun 2012;3:881.
32. Chisholm D, Evans DB. Improving health system efficiency as a means of moving towards universal coverage. Geneva, Switzerland: World Health Organization, 2010.
33. Cotter C, Sturrock HJ, Hsiang MS, et al. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet 2013;382:900-11.
34. Stanton MC, Bockarie MJ, Kelly-Hope LA. Geographical factors affecting bed net ownership, a tool for the elimination of anopheles-transmitted lymphatic filariasis in hard-to-reach communities. PLoS ONE 2013;8:e53755.